Sunday, August 23, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma DemandtodayDEFENSEOracle Lands a $7B Pentagon Software Contract — and the Market Should Take It Seriously4 weeks agoTECHD-Wave Wins Canadian Quantum Funding for AnnealingtodayDEFENSEThe U.S.-Iran War Is Costing $37.5B and Counting — Here's Where That Money Goes4 weeks agoENERGYEnbridge Wins Federal Permit for Line 5 TunnelyesterdayENERGYTrump Signs the Saudi Nuclear Deal — and U.S. Uranium and Reactor Companies Are the Quiet Winners4 weeks agoENERGYFederal Court Orders Enbridge Line 5 RemovalyesterdayCRYPTOThe Senate's Landmark Crypto Bill Creates Winners Inside the ETF and Exchange Stack4 weeks agoWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. PersonsyesterdayWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Military Supply Chain — These Miners Fill the Gap4 weeks agoHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpayment2 days agoMARKETSChina's $765M Antitrust Fine on Trip.com Is a Warning Shot for U.S.-Listed Chinese Consumer Stocks4 weeks agoENERGYNewsom Passes Diablo Canyon Decision to Successor3 days agoTRADE & TARIFFSTariffs on Indian Pharma Are Coming — and U.S. Generic Drug Buyers Will Pay the Bill4 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervalued4 days agoHEALTHCARE & FDACMS's Star Ratings Overhaul Rescues the Biggest Medicare Advantage Insurers — For Now4 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Win4 days agoDEFENSEPentagon's $7B Oracle Software Deal Is One of the Cleanest Defense-Tech Wins in Years4 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnostics5 days agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Direct Win for Oracle, Pressure on Smaller Defense IT Rivals4 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopoly5 days agoTECHFCC Tightens Submarine Cable Licensing Rules—Tech Giants Face New Compliance Costs, Telecom Carriers Gain Regulatory Clarity4 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfall5 days agoHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—UnitedHealth, Humana, and Anthem Positioned to Gain from Simplified Metrics4 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Eases5 days agoDEFENSEHouse Passes $1.15 Trillion Defense Bill—Lockheed, Raytheon, and General Dynamics Positioned for Record Spending4 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demand6 days agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years4 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressure6 days agoDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset4 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boost6 days agoHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten4 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Pathlast weekDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation4 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue4 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persistslast weekCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity4 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refundlast weekHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem4 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makerslast weekDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue3 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Winslast weekDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue3 weeks agoDEFENSEBlackSky Lands Multi-Year Satellite Contractlast weekMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue3 weeks agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibilitylast weekENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors3 weeks agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contractlast weekSEARCH DEMANDCasgevy List Price: $2.2 Million3 weeks agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestocklast weekSEARCH DEMANDData Center Power Exchange3 weeks agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Casklast weekTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall3 weeks agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidancelast weekTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing3 weeks agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacinglast weekHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win3 weeks agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shiftlast weekDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue3 weeks agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gainslast weekWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market3 weeks agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertaintylast weekHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption3 weeks agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio2 weeks agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk3 weeks agoDEFENSEPentagon Awards Space-Based Target Tracking Contracts2 weeks agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze3 weeks agoENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes2 weeks agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win3 weeks agoWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers2 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure3 weeks agoTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing2 weeks agoHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief3 weeks agoTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout2 weeks agoTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone2 weeks agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma2 weeks agoDEFENSERising Defense Spending Lifts Northrop Grumman Outlook2 weeks agoHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices2 weeks agoMARKETSFTC Threatens Booking Holdings Over Priceline Practices2 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

Trump Vaccine Spacing Order Reshapes Pharma Demand

Executive order to space out childhood vaccines shifts demand away from combination shots toward single-antigen products.

Image: Money Racket
By at Money Racket · Aug 23, 2026
1-YEAR MOVE
+14% −4%
PFE ▼3.6%
1-year price move by ticker
TickerCompany1-year change
PFEPfizer−3.6%

President Trump signed an executive order directing the CDC to review and potentially space out the childhood vaccine schedule, moving away from combination vaccines toward single-antigen shots administered over a longer timeline. The order reflects vaccine-skeptic pressure and could reshape pharmaceutical demand.

Vaccine spacing order threatens combination shot demand for Merck and Pfizer while raising costs for providers.

Merck MRK and Pfizer PFE manufacture most combination vaccines (Pentacel, Pediarix, Kinrix, Quadracel) and face potential demand loss if spacing reduces combination shot uptake. Moderna MRNA has limited pediatric exposure but could benefit if new vaccine development is mandated. Seqirus (CSL subsidiary, Australian-listed) manufactures flu vaccines and faces uncertainty if spacing extends to seasonal shots.

Single-antigen vaccine manufacturers and contract manufacturers like Emergent BioSolutions (EBS) could benefit if spacing drives demand for separate, smaller-volume shots. However, the net effect is likely negative: spacing typically reduces overall vaccination rates and total vaccine doses administered, shrinking the addressable market.

Pediatric healthcare providers and pediatricians face operational complexity and higher administration costs if they must schedule more frequent visits. CVS Health CVS and Walgreens (WBA) operate vaccination clinics and will see higher labor costs and lower throughput per visit.

Watch for CDC guidance and state-level adoption. If spacing becomes standard, pediatric vaccination rates will decline, reducing pharma revenue and creating public health risks that could trigger regulatory reversal.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/trump-vaccine-spacing-order-reshapes-pharma-demand-pediatric-focus/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →